FDA Commissioner Marty Makary Resigns Amid Regulatory and Pro-Life Tensions

Marty Makary has resigned as FDA commissioner following reported internal tensions regarding e-cigarette regulations and criticism from pro-life advocacy groups. These groups accuse him of delaying a necessary safety review of the abortion pill mifepristone, highlighting a clash between regulatory caution and moral imperatives. His departure signals a significant shift in federal health oversight with implications for how the administration balances scientific data with ethical concerns.